
John C. Fox
Examiner (ID: 3915)
| Most Active Art Unit | 3753 |
| Art Unit(s) | 3407, 3753, 2899, 2602, 3727 |
| Total Applications | 3766 |
| Issued Applications | 2890 |
| Pending Applications | 143 |
| Abandoned Applications | 734 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18434313
[patent_doc_number] => 20230181607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/924662
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924662 | Thiosaccharides for use in treating coronavirus infection | May 10, 2021 | Issued |
Array
(
[id] => 17168789
[patent_doc_number] => 20210322459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => PROPHYLACTIC USE OF INULIN AGAINST SINUSITIS
[patent_app_type] => utility
[patent_app_number] => 17/315436
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315436
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315436 | Prophylactic use of inulin against sinusitis | May 9, 2021 | Issued |
Array
(
[id] => 17050652
[patent_doc_number] => 20210260086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/315144
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315144
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315144 | METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS | May 6, 2021 | Abandoned |
Array
(
[id] => 18420220
[patent_doc_number] => 20230174681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => PARAMYLON-BASED RESIN, MOLDING MATERIAL, MOLDED BODY, AND PRODUCTION METHOD FOR PARAMYLON-BASED RESIN
[patent_app_type] => utility
[patent_app_number] => 17/923787
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923787 | Paramylon-based resin, molding material, molded body, and production method for paramylon-based resin | May 6, 2021 | Issued |
Array
(
[id] => 18405798
[patent_doc_number] => 20230167149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS
[patent_app_type] => utility
[patent_app_number] => 17/997374
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997374 | CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS | Apr 29, 2021 | Abandoned |
Array
(
[id] => 18525467
[patent_doc_number] => 11712445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Compositions and methods for improving gastrointestinal function in subjects with renal disease
[patent_app_type] => utility
[patent_app_number] => 17/246433
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3204
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246433 | Compositions and methods for improving gastrointestinal function in subjects with renal disease | Apr 29, 2021 | Issued |
Array
(
[id] => 18466894
[patent_doc_number] => 20230201174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/996816
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996816 | COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES | Apr 19, 2021 | Pending |
Array
(
[id] => 18451628
[patent_doc_number] => 20230192907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID AND HYALURONIC ACID SO OBTAINED
[patent_app_type] => utility
[patent_app_number] => 17/918659
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918659 | PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID AND HYALURONIC ACID SO OBTAINED | Apr 15, 2021 | Pending |
Array
(
[id] => 17020987
[patent_doc_number] => 20210244858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => SOFT TISSUE FILLER COMPOSITION WITH HYALURONIC ACID AND BENZYL ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 17/227714
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227714 | SOFT TISSUE FILLER COMPOSITION WITH HYALURONIC ACID AND BENZYL ALCOHOL | Apr 11, 2021 | Abandoned |
Array
(
[id] => 20264108
[patent_doc_number] => 12435084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Indazole derivatives as inhibitors of SARM1
[patent_app_type] => utility
[patent_app_number] => 17/995046
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25503
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995046 | Indazole derivatives as inhibitors of SARM1 | Apr 6, 2021 | Issued |
Array
(
[id] => 18374353
[patent_doc_number] => 20230149432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection
[patent_app_type] => utility
[patent_app_number] => 17/995228
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995228 | Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection | Apr 5, 2021 | Pending |
Array
(
[id] => 18948130
[patent_doc_number] => 11891411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Industrial utilization method for
[patent_app_type] => utility
[patent_app_number] => 17/216928
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5753
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216928 | Industrial utilization method for | Mar 29, 2021 | Issued |
Array
(
[id] => 18626644
[patent_doc_number] => 20230285442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING VIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/914225
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914225 | USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING VIRAL AGENTS | Mar 25, 2021 | Pending |
Array
(
[id] => 19246788
[patent_doc_number] => 20240197772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac
[patent_app_type] => utility
[patent_app_number] => 17/909854
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909854 | COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac | Mar 23, 2021 | Pending |
Array
(
[id] => 18312639
[patent_doc_number] => 20230116539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Collagenase Activity Inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/913874
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913874 | Collagenase Activity Inhibitor | Mar 21, 2021 | Pending |
Array
(
[id] => 18359381
[patent_doc_number] => 20230140972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => GLYCEROL GLUCOSIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME FOR ULTRAVIOLET LIGHT SHIELD OR ANTI-INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/912340
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912340 | GLYCEROL GLUCOSIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME FOR ULTRAVIOLET LIGHT SHIELD OR ANTI-INFLAMMATION | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18338185
[patent_doc_number] => 20230130134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/906459
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906459
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906459 | METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF | Mar 15, 2021 | Pending |
Array
(
[id] => 17095369
[patent_doc_number] => 20210283160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => VIRAL INHIBITION
[patent_app_type] => utility
[patent_app_number] => 17/201621
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201621 | Viral inhibition | Mar 14, 2021 | Issued |
Array
(
[id] => 19622825
[patent_doc_number] => 12161616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Combination therapy comprising an omega-3 fatty acid, a folate species and a vitamin B12 species
[patent_app_type] => utility
[patent_app_number] => 17/194517
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 14931
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194517
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194517 | Combination therapy comprising an omega-3 fatty acid, a folate species and a vitamin B12 species | Mar 7, 2021 | Issued |
Array
(
[id] => 18287127
[patent_doc_number] => 20230102599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => HIGHLY RESISTANT STARCH AND MANUFACTURING PROCESS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/904933
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904933 | HIGHLY RESISTANT STARCH AND MANUFACTURING PROCESS THEREFOR | Feb 25, 2021 | Pending |